On the 27th, the inauguration ceremony of YTS Asia was held.

To celebrate the establishment of the YTS Asia branch, James Lee, 

the CEO of YTS Global Headquarters in the U.S., and related companies attended and honored the event.

From the left, Kim Myung-seok, managing director of Kb-Med, Park Se-yeol, CEO of KB-Med, Seok Do-soo, co-chairman of Solgent, and Han Dong-geun, Korea branch manager of YTS Global.

As Covid-19 patients get overed 1.5 million worldwide, 

the number of countries requesting the supply of diagnosis kit exceeds 120, 

and Korean diagnostic technology is bringing worldwide attention.

YTS Global supplied domestic diagnostic kit by contributing to registration with the US federal government supplier.

The rest has been omitted.

For more information, please refer to the attached link.

(From the left) Se-Yeoul Park, CEO of KB Med, Do-Soo Seok, Co-CEO of Solgent, Jae-Hyung Yoo, Co-CEO of Solgent, Dong-Geun Han, Director of YTS Global Korea

Domestic bio company, first supply of diagnostic kit for Covid-19 

to U.S. Federal Emergency Management Agency(FEMA) 

On the 7th, Solgent, a venture company in Daejeon announced that it would be nation's 

first procurement of self-developed Covid-19 diagnostic reagent to the U.S. Federal Emergency Management Agency (FEMA).

As Solgent was registered with US federal suppliers, the way has opened to export over 40 diagnostic reagents including Covid-19 diagnostic reagents.

Solgent explained that this achievement owe to the cooperation of strong ROK-US alliance with President Donald Trump and President Moon jae-in.

In addition, it said that YTS Global Inc., which manages the delivery of the U.S. Federation, played the most important role, 

and cooperation between Han Dong-geun, director of YTS Global Korea and Se-Yeoul Park, president of KB Med, also took an important part.

The rest has been omitted.

For more information, please refer to the attached link.